Mp72-13 Ship-1 Activation Provides Significant Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Results of a Phase 2 Randomized Placebo Controlled Trial
Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.1626
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)